| # | Drug | Count |
|---|---|---|
| 0 | LEVOTHYROXINE SODIUM | 138 |
| 1 | CABOZANTINIB | 76 |
| 2 | ASPIRIN | 56 |
| 3 | ASPIRIN 325 MG | 53 |
| 4 | ASPIRIN 81 MG | 53 |
| 5 | ACETAMINOPHEN | 48 |
| 6 | PREDNISONE | 38 |
| 7 | AMLODIPINE | 36 |
| 8 | LEVOTHYROXINE SODIUM ANHYDROUS | 36 |
| 9 | PANTOPRAZOLE | 36 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | EPLONTERSEN | 1 | 0.0057 |
| 1 | PHENAZOPYRIDINE HYDROCHLORIDE | 1 | 0.0030 |
| 2 | RILONACEPT | 3 | 0.0026 |
| 3 | SODIUM PHENYLBUTYRATE | 1 | 0.0024 |
| 4 | BEXAROTENE | 3 | 0.0023 |
| 5 | URINARY PAIN RELIEF | 1 | 0.0021 |
| 6 | ROLAPITANT | 1 | 0.0019 |
| 7 | ETHACRYNIC ACID | 1 | 0.0018 |
| 8 | CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN AND POLYSORBATE 80 | 1 | 0.0018 |
| 9 | CABOZANTINIB | 76 | 0.0016 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 85 |
| 1 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 81 |
| 2 | Corticosteroid [EPC] | 78 |
| 3 | Kinase Inhibitor [EPC] | 73 |
| 4 | Platelet Aggregation Inhibitor [EPC] | 57 |
| 5 | Provitamin D2 Compound [EPC] | 55 |
| 6 | Benzodiazepine [EPC] | 50 |
| 7 | Vitamin C [EPC] | 39 |
| 8 | Dihydropyridine Calcium Channel Blocker [EPC] | 37 |
| 9 | Calcium Channel Blocker [EPC] | 36 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 3 | 0.0044 |
| 1 | Guanylate Cyclase-C Agonist [EPC] | 4 | 0.0019 |
| 2 | Provitamin D2 Compound [EPC] | 55 | 0.0018 |
| 3 | Cortisol Synthesis Inhibitor [EPC] | 1 | 0.0013 |
| 4 | Adrenocorticotropic Hormone [EPC] | 1 | 0.0011 |
| 5 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 81 | 0.0008 |
| 6 | Type I Interferon Receptor Antagonist [EPC] | 1 | 0.0005 |
| 7 | Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor [EPC] | 1 | 0.0004 |
| 8 | Neurokinin 3 Receptor Antagonist [EPC] | 1 | 0.0004 |
| 9 | Human Immunoglobulin G [EPC] | 9 | 0.0004 |